<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.openbell.ai/</loc>
    <lastmod>2026-11-02T03:51:30.122Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/support</loc>
    <lastmod>2026-11-02T03:51:30.122Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/privacy</loc>
    <lastmod>2026-11-02T03:51:30.122Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/terms</loc>
    <lastmod>2026-11-02T03:51:30.122Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/feed.json</loc>
    <lastmod>2026-11-02T03:51:30.122Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AVR:1793585014000</loc>
    <lastmod>2026-11-02T02:03:34.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AVR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Anteris Technologies Reports Positive 30-Day Outcomes for Medium-Size DurAVR THV in EMBARK Study</image:title>
      <image:caption>Anteris Technologies reported positive 30-day results for the medium-size DurAVR transcatheter heart valve in 22 EMBARK study patients with severe aortic stenosis and medium aortic annuli. The valve’s effective orifice area averaged 2.64 ± 0.19 cm², up from a baseline of 0.8 ± 0.2 cm², while the mean pressure gradient was 6.17 ± 1.40 mmHg. No valve-related deaths, moderate or severe paravalvular leaks, or prosthesis-patient mismatch were reported at 30 days; the article gave no financial results or stock-price impact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/OABI:1793585007000</loc>
    <lastmod>2026-11-02T02:03:27.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OABI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>OmniAb Achieves Self-Sustaining Cash Flow</image:title>
      <image:caption>OmniAb said it has achieved self-sustaining cash flow and no longer needs external investor funding to maintain operations. The company cited contractually protected options on hundreds of programs, with potential milestone payments exceeding $3 billion, and is targeting break-even net cash use by 2026. The article did not report revenue, profit, or a stock-price reaction.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VG:1793584907000</loc>
    <lastmod>2026-11-02T02:01:47.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Venture Global Commences Commercial Operations of Phase One of Plaquemines LNG</image:title>
      <image:caption>Venture Global announced that Phase One of its Plaquemines LNG export facility has begun commercial operations. The facility uses the company’s modular technology to liquefy and export natural gas to international markets, expanding its LNG infrastructure along the U.S. Gulf Coast. The article did not report financial figures or a stock-price impact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HBM:1793563314000</loc>
    <lastmod>2026-11-01T20:01:54.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HBM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HORNBACH Baumarkt AG Reports 6M 2026/27 Financial Results</image:title>
      <image:caption>HORNBACH Baumarkt AG reported first-half 2026/27 sales of €3,816.2 million, up 6.0% year over year, and adjusted EBIT of €285.6 million, up 4.9%. Free cash flow was €194.9 million. The company cited expansion plans, e-commerce growth and stronger cash flow, and maintained its outlook for sales at or slightly above the prior-year level and adjusted EBIT at the prior-year level.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PERI:1793559704000</loc>
    <lastmod>2026-11-01T19:01:44.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PERI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Perion Network Enters into Definitive Merger Agreement with Affle</image:title>
      <image:caption>Perion Network agreed to be acquired by Affle 3iL for $11.70 per share in cash, valuing the company at approximately $420 million. The offer represents a 34.5% premium to Perion’s October 30, 2026 closing share price, and was unanimously approved by Perion’s board. A 40-day go-shop period allows Perion to seek alternative proposals; the deal is expected to close in early 2027, subject to regulatory and shareholder approvals. Upon completion, Perion shares will be delisted from Nasdaq and the Tel Aviv Stock Exchange.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/KESKOB:1793559699000</loc>
    <lastmod>2026-11-01T19:01:39.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KESKOB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Kesko Raises Financial Guidance Following Q3 Profit Growth</image:title>
      <image:caption>Kesko raised its financial guidance after reporting profit growth in the third quarter. The article does not provide specific financial figures or details about the revised outlook.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MARUTI:1793547119000</loc>
    <lastmod>2026-11-01T15:31:59.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MARUTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Maruti Suzuki Reports Record October Sales with 25% Growth</image:title>
      <image:caption>Maruti Suzuki India reported record October 2026 sales, up 25% year over year, citing strong festive-season demand for its vehicle portfolio. The report did not provide sales totals, financial results, or stock-price movements.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BTAI:1793541837000</loc>
    <lastmod>2026-11-01T14:03:57.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BTAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BioXcel Therapeutics Announces Executive Changes and Wind-Down Process</image:title>
      <image:caption>BioXcel Therapeutics announced on October 30, 2026, that it terminated four officers and appointed Samir Saleem as president and secretary. The leadership changes come amid a court-supervised bankruptcy sale and the planned wind-down of the company’s affairs. Its stock is trading under the ticker BTAIQ.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NERD:1793541836000</loc>
    <lastmod>2026-11-01T14:03:56.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NERD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nerds On Site Reports Q1 Fiscal 2027 Financial Results</image:title>
      <image:caption>Nerds On Site reported a 76% improvement in operating results and a 63% reduction in shareholder loss in the first quarter of fiscal 2027 compared with the prior period. Canadian recurring revenue grew nearly 8%, while operating expenses fell 12%. The company said it is focused on improving operating cash generation and liquidity and expanding opportunities in managed services, cybersecurity, AI products, and U.S. technical services, including AI-enhanced internal and client-facing capabilities.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MBIO:1793541832000</loc>
    <lastmod>2026-11-01T14:03:52.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Mustang Bio Announces FDA Acceptance of IND Application for MB-109</image:title>
      <image:caption>Mustang Bio announced that the FDA accepted its Investigational New Drug application for MB-109, a novel combination of the company’s MB-101 and MB-108 assets. The candidate is intended to treat recurrent glioblastoma and high-grade astrocytoma. The announcement was reported on October 30, 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/USCM:1793541824000</loc>
    <lastmod>2026-11-01T14:03:44.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/USCM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Critical Metals Corp. Receives Supreme Court Approval for European Lithium Acquisition</image:title>
      <image:caption>Critical Metals Corp. (Nasdaq: CRML) received Supreme Court of Western Australia approval for its proposed acquisition of 100% of European Lithium’s issued share capital and all listed options through a scheme of arrangement. The deal consideration will be paid in newly issued Critical Metals shares. The approval follows favorable votes by European Lithium shareholders and option holders on October 22, 2026, allowing the share issuance to proceed.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SRTS:1793541783000</loc>
    <lastmod>2026-11-01T14:03:03.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SRTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Sensus Healthcare Reports Q2 2026 Financial Results and Analyst Rating Update</image:title>
      <image:caption>Sensus Healthcare reported a significant revenue decline and an adjusted net loss in Q2 2026. Unit sales fell to 11 after eight funded units were delayed; the units have since been approved and are expected to be recognized in Q3. Lake Street maintained its Buy rating on SRTS but lowered its price target from $4.50 to $4.00.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/JRSH:1793541778000</loc>
    <lastmod>2026-11-01T14:02:58.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/JRSH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Jerash Holdings Reports Quarterly Financial Results and Receives Analyst Price Target Increase</image:title>
      <image:caption>Jerash Holdings reported quarterly revenue of $50.2 million, up 27% year over year, and net income of $1.7 million, with a gross margin of 16%. Management attributed the results to improved manufacturing efficiency and higher shipment volumes to the United States. DA Davidson maintained its buy rating and raised its price target from $5.00 to $6.00 per share.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/EMBC:1793541750000</loc>
    <lastmod>2026-11-01T14:02:30.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EMBC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Embecta Reports Fiscal Third-Quarter 2026 Financial Results and Updates Guidance</image:title>
      <image:caption>Embecta reported fiscal third-quarter 2026 revenue of approximately $272 million, down 8.1% year over year. It reaffirmed full-year revenue guidance of $1.015 billion to $1.035 billion, while raising adjusted EPS guidance to $1.80–$1.90 and adjusted operating margin guidance to 23.5%–24%, citing the earlier-than-expected close of its Owen Mumford acquisition. The company also highlighted its Adaptis auto-injector, generated $41 million in free cash flow, and repaid $53 million of debt.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GO:1793541737000</loc>
    <lastmod>2026-11-01T14:02:17.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Grocery Outlet Shares Surge Following Strong Earnings and Analyst Upgrade</image:title>
      <image:caption>Grocery Outlet Holding Corp. shares surged 38.8% on October 31, 2026, their largest single-day gain on record. The rise followed the company’s optimistic earnings-per-share and profit forecasts, alongside a Morgan Stanley upgrade of its stock rating.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/IRMD:1793541733000</loc>
    <lastmod>2026-11-01T14:02:13.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IRMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>iRadimed Reduces Full-Year Guidance Amid Production Constraints</image:title>
      <image:caption>iRadimed Corporation lowered its full-year guidance because quality-related constraints slowed its production ramp-up. Demand for its four-channel 3870 infusion pump remains strong, supporting bookings and backlog as existing and new customers replace legacy devices. The article did not provide specific financial figures or report a stock-price movement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/XPEV:1793538116000</loc>
    <lastmod>2026-11-01T13:01:56.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/XPEV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>XPeng Announces Record Vehicle Deliveries for October 2026</image:title>
      <image:caption>XPeng delivered a record 50,237 vehicles in October 2026, up 22% month over month and 20% year over year. Overseas deliveries reached a record 13,326 units, a 166% increase from a year earlier. The company launched the XPeng L05 in mainland China, with customer deliveries set to begin November 1, and secured a Level 4 Robotaxi demonstration-operation license in Guangzhou on October 26, advancing its Physical AI commercialization efforts.</image:caption>
    </image:image>
  </url>
</urlset>